Axsome Therapeutics said on Tuesday it will narrow the focus of a late-stage study of its depression drug after an initial run of the trial showed improvement only in a small subgroup of patients.

Elon Musk's brain implant company Neuralink is planning to raise about $500 million at a pre-money valuation of $8.5 billion, ...

The National Society for the Prevention of Cruelty to Children (NSPCC) say on its website: "Signs of depression or anxiety in ...

I sat down with Sony World Photographer of the Year, Zed Nelson, to discuss his award-winning project and approach to making ...

This is the official YouTube page of Law Nation Sports. It is the perfect way to keep up with everything about sports and ...

This is the official YouTube page of Law Nation Sports. It is the perfect way to keep up with everything about sports and ...

"name": "GPT - Billboard - Slot Inline - Content - Labeled - No Desktop", "component": "23668565", "insertPoint": "2", ...

A synthetic variant of the plant-based drug poses risks. A kratom retailer wants to see products pulled from Arizona shelves.

Brian Fanion says he and his wife Amy Fanion had been arguing about his retirement plans when she picked up his service weapon and shot herself. Investigators did not believe his story.

Only eight theaters in the U.S. are showing "Sinners" as director Ryan Coogler intended it to be seen. One is in the Valley.